Lloyds Bank PLC Publication of Suppl.Prospcts (3294S)
March 08 2023 - 7:59AM
UK Regulatory
TIDM88CS
RNS Number : 3294S
Lloyds Bank PLC
08 March 2023
RNS Announcement
Lloyds Bank plc
Publication of Supplementary Prospectus
8 March 2023
The following Supplementary Prospectus has been approved by the
Financial Conduct Authority and is available for viewing.
Supplementary Prospectus dated 8 March 2023 (the Supplementary
Prospectus) relating to the EUR 60,000,000,000 Global Covered Bond
Programme of Lloyds Bank plc, unconditionally and irrevocably
guaranteed as to payments of interest and principal by Lloyds Bank
Covered Bonds LLP.
The Supplementary Prospectus should be read and construed in
conjunction with the prospectus dated 18 August 2022, as
supplemented by the supplementary prospectus dated 28 October 2022
(together, the Prospectus).
To view the Supplementary Prospectus, please paste the following
URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/3294S_1-2023-3-8.pdf
The Supplementary Prospectus has been submitted to the National
Storage Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
For further information, please contact:
Investor Relations:
Douglas Radcliffe
Group Investor Relations Director
Tel: +44 (0) 20 7356 1571
E-mail: douglas.radcliffe@lloydsbanking.com
Corporate Affairs:
Matt Smith
Head of Media Relations
Tel: +44 (0) 20 7356 3522
E-mail: matt.smith@lloydsbanking.com
Lloyds Bank plc
Registered Office
25 Gresham Street
London EC2V 7HN
Disclaimer - Intended Addressees
Please note that the information contained in this announcement
and the Supplementary Prospectus may be addressed to and/or
targeted at persons who are residents of particular countries
(specified in the Prospectus) only and is not intended for use and
should not be relied upon by any person outside these countries
and/or to whom this announcement and the Supplementary Prospectus
are not addressed. Prior to relying on the information contained in
this announcement and the Supplementary Prospectus, you must
ascertain from the Prospectus whether or not you are one of the
intended addressees of the information contained in this
announcement and the Supplementary Prospectus.
In particular, this announcement and the Supplementary
Prospectus do not constitute an offer or invitation to subscribe
for, or purchase, securities in the United States or in any other
jurisdiction where such an offer or invitation would be unlawful.
This announcement and the Supplementary Prospectus are not for
distribution in the United States or to U.S. persons (as defined
below) other than to qualified institutional buyers within the
meaning of and in reliance on Rule 144A of the U.S. Securities Act
of 1933, as amended (the Securities Act). The securities described
herein have not been, and will not be, registered under the
Securities Act or under any relevant securities laws of any state
of the United States of America and are subject to U.S. tax law
requirements. The securities may not be offered or sold within the
United States or to, or for the account or benefit of, U.S. persons
or to persons within the United States of America (as such terms
are defined in Regulation S under the Securities Act) except
pursuant to registration or an exemption from the registration
requirements of the Securities Act. There will be no public
offering of the securities in the United States. For a description
of the restrictions on offers and sales of the securities described
herein, please refer to the Supplementary Prospectus and the
Prospectus.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PSPFLFEFVDITIIV
(END) Dow Jones Newswires
March 08, 2023 07:59 ET (12:59 GMT)
Lloyds Bk. 50 (LSE:88CS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Lloyds Bk. 50 (LSE:88CS)
Historical Stock Chart
From Dec 2023 to Dec 2024